Reduction-responsive supramolecular hybridized paclitaxel nanoparticles for tumor treatment

Reduction-responsive supramolecular hybridized paclitaxel nanoparticles for tumor treatment

Powerful chemotherapeutics have been used to combat tumor cells, but serious adverse effects and poor therapeutic efficiency restrict their clinical performance. Herein, we developed reduction-responsive supramolecular hybridized paclitaxel nanoparticles (PTX@HOMNs) for improved tumor treatment. The...

Full description

Bibliographic Details
Main Authors: Yuhan Wang, Yingli Cui, Tinggeng Dai, Ying Yue
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
paclitaxel
organosilica
reduction-responsive
controlled drug release
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1257788/full

Similar Items

Similar Items